Keywords: gsk, tykerb, plus, xeloda, superior, alone, says

GSK's Tykerb plus Xeloda superior to Xeloda alone, says NEJM study

Article | 08 January 2007

Print This

UK drug major GlaxoSmithKline says that new Phase III data published in the December 28 issue of the New England Journal ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in